MedPath

Effects of Liquid Zinc Supplementation and Dispersible Zinc Tablets on Plasma Zinc Concentration

Not Applicable
Completed
Conditions
Zinc Deficiency
Registration Number
NCT00944853
Lead Sponsor
University of California, Davis
Brief Summary

The study aims to compare the effects of two different formulations of zinc supplements on plasma zinc concentrations among young Burkinabe children.

Detailed Description

1) To investigate the effects of short-term zinc supplementation, provided either as a dispersible tablet containing zinc sulfate ("ZinCfant," Nutriset Ltd; Malaunay, France) or as a liquid ZnSO4 solution, on changes in serum zinc concentration, compared with a placebo in young Burkinabe children; and 2) to assess the relationship between change in serum zinc concentration and the presence of altered intestinal permeability within each treatment group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
462
Inclusion Criteria
  • currently breast feeding
  • informed consent of a parent or guardian.
Exclusion Criteria
  • symptomatic acute or chronic febrile infections
  • diarrhea within the past week
  • consuming vitamin or mineral supplements or zinc-fortified infant formulas

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Plasma zinc concentration3 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Toussiana Health District

🇧🇫

Toussiana, Burkina Faso

Toussiana Health District
🇧🇫Toussiana, Burkina Faso

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.